<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Mon, 13 Apr 2026 16:08:32 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/dioscin/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[盎真科研造假Anticancer activity of Dioscin against Lymphoid Malignant Cells via activation ROS-JNK attenuation Nrf2 NF-κB新加坡安瑟出版 浙大林佑杰 Yu Kiat Lin 山东吴庆珂 Zhejiang University Malaya谢敬艺 陕西省人民医院]]></title><description><![CDATA[盎真科研国际SCI学术论文代写挂名造假服务 Anzen Science SCI Research Paper Ghostwrite Pay to Put your Name as Author 马来亚大学浙江大学林佑杰 山东师范吴庆珂 宽中谢敬艺 Anzen Science Company / stm / Twitter / FB 吴庆珂 Wu Qingke 上海盎真科技有限公司共同创始人 Shanghai]]></description><link>http://direct.ecency.com/dioscin/@bsfmalaysia/anticancer-activity-of-dioscin-against</link><guid isPermaLink="true">http://direct.ecency.com/dioscin/@bsfmalaysia/anticancer-activity-of-dioscin-against</guid><category><![CDATA[dioscin]]></category><dc:creator><![CDATA[bsfmalaysia]]></dc:creator><pubDate>Mon, 02 May 2022 00:44:12 GMT</pubDate><enclosure url="https://images.ecency.com/p/6VvuHGsoU2QCK6yq1XKF2xrUpxynFs9SFNnn3DQjww5gXiDJ96xWaYb7Dxrs76iRiKwwZfZuFUtQccXD1HQ2VNu393Uh1dTZHJBMfsQnAaxkCVNjX4m7SBqsHK8vKg?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>